Advertisement

Picture [iito] Life Science Business Portals Media Data 2022 650x100px
Organisation › Details

EnBiotix Inc.

Enbiotix is a privately-held, rare disease company with an initial focus on chronic respiratory diseases. EnBiotix is headquartered in Boston, Massachussets, USA with its affiliate, EnBiotix, GmbH based in Leipzig, Germany. *

 

Period Start 2016-11-03 existent
  Group Spexis (Group)
Products Industry antibiotic
  Industry 2 drug development
Person Person Wager, Jeffrey D. (EnBiotix 201611 CEO)
     
Region Region Cambridge, MA
  Country United States (USA)
  Street 77 Massachusetts Avenue
MIT
  City 02139 Cambridge, MA
    Address record changed: 2021-11-06
     
Basic data Employees n. a.
     
    * Document for �About Section�: Polyphor Ltd.. (9/1/21). "Press Release: Polyphor and EnBiotix Announce Signing of Merger Agreement and Sale of Inhaled Murepavadin to EnBiotix". Allschwil.
     
   
Record changed: 2021-11-06

Advertisement

Picture [iito] Made Without Love 650x100px

More documents for Spexis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top